Edwards James Michael

Chief Financial OfficerbioAffinity Technologies, Inc. (BIAF) · full profile →Form 4 · filed Nov 29, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
3 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 17, 2022Grant(A)4K$037K
Sep 6, 2022Conversion(C)2K$4.20$9K33K
Sep 1, 2022Buy(P)2K30K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 6, 2022Grant(A)7612K
Sep 6, 2022Conversion(C)2K$00
Sep 1, 2022Buy(P)2K2K
Sep 1, 2022Buy(P)2K2K
Jul 20, 2022Grant(A)0761

Transaction Codes

A
Grant / award
C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-033932) within minutes of acceptance. Every field above traces to the original document. Verify it directly: